How much does Akeega (Niraparib Tosylate and Abiraterone Acetate Tablets) Cost& price without insurance in China?
Akeega® is the commercial brand name of Niraparib Tosylate and Abiraterone Acetate Tablets, an oral fixed-dose combination drug developed by Johnson & Johnson. It combines PARP inhibitor niraparib and androgen synthesis inhibitor abiraterone to block dual pathogenic pathways of advanced prostate cancer.
Main Indications
Treatment of adult patients with metastatic castration-resistant prostate cancer harboring BRCA1/BRCA2 gene mutation.
Common Side Effects
Common mild adverse reactions: Fatigue, anemia, nausea, hypertension and decreased appetite.
Laboratory abnormalities: Neutropenia, thrombocytopenia and transient hepatic enzyme elevation.
Severe but manageable risks: Severe myelosuppression, adrenal insufficiency and hypersensitivity reactions.
Approval Status in China
Akeega® (Niraparib Tosylate and Abiraterone Acetate Tablets, 50mg/500mg) was officially approved for marketing in China in 2024. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Akeega (Niraparib Tosylate and Abiraterone Acetate Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
